Bridging data across studies using frequentist and Bayesian estimation.
J Biopharm Stat
; 27(3): 426-441, 2017.
Article
em En
| MEDLINE
| ID: mdl-28287342
ABSTRACT
In drug development programs, an experimental treatment is evaluated across different populations and/or disease types using multiple studies conducted in countries around the world. In order to show the efficacy and safety in a specific population, a bridging study may be required. There are therapeutic areas for which enrolling patients to a trial is very challenging. Therefore, it is of interest to utilize the available historical information from previous studies. However, treatment effect may vary across different subpopulations/disease types; therefore, directly utilizing outcomes from historical studies may result in a biased estimation of treatment effect under investigation in the target trial. In this article, we propose novel approaches using both frequentist and Bayesian frameworks that allow borrowing information from historical studies while accounting for relevant patient's covariates via a propensity-based weighting. We evaluate the operating characteristics of the proposed methods in a simulation study and demonstrate that under certain conditions these methods may lead to improved estimation of a treatment effect.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Projetos de Pesquisa
/
Ensaios Clínicos como Assunto
/
Teorema de Bayes
Tipo de estudo:
Prognostic_studies
Limite:
Humans
Idioma:
En
Ano de publicação:
2017
Tipo de documento:
Article